Organogenesis Holdings Inc (NASDAQ: ORGO) on Friday, soared 9.18% from the previous trading day, before settling in for the closing price of $5.12. Within the past 52 weeks, ORGO’s price has moved between $2.61 and $7.08.
The company achieved an average annual earnings per share of 1600.00%. With a float of $59.79 million, this company’s outstanding shares have now reached $126.91 million.
Organogenesis Holdings Inc (ORGO) Breakdown of a Key Holders of the stock
Observing investor behavior towards Drug Manufacturers – Specialty & Generic industry stocks is more important than anything else. The insider ownership of Organogenesis Holdings Inc is 52.89%, while institutional ownership is 54.12%. The most recent insider transaction that took place on May 14 ’25, was worth 775,041. In this transaction Director of this company bought 251,001 shares at a rate of $3.09, taking the stock ownership to the 251,001 shares. Before that another transaction happened on May 15 ’25, when Company’s Director bought 107,494 for $2.99, making the entire transaction worth $320,999. This insider now owns 358,495 shares in total.
Organogenesis Holdings Inc (ORGO) Recent Fiscal highlights
As on 12/31/2024, Multinational firm has announced its last quarter scores, in which it reported 0.07 earnings per share (EPS) for the period topping the consensus outlook (set at 0.02) by 0.05. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.09 per share during the current fiscal year.
Organogenesis Holdings Inc (NASDAQ: ORGO) Trading Performance Indicators
Organogenesis Holdings Inc (ORGO) is currently performing well based on its current performance indicators. A quick ratio of 2.88 was reported for the most recent quarter. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 1.52.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.10, a number that is poised to hit 0.21 in the next quarter and is forecasted to reach 0.17 in one year’s time.
Technical Analysis of Organogenesis Holdings Inc (ORGO)
Looking closely at Organogenesis Holdings Inc (NASDAQ: ORGO), its last 5-days average volume was 1.84 million, which is a jump from its year-to-date volume of 1.44 million. As of the previous 9 days, the stock’s Stochastic %D was 11.13%.
During the past 100 days, Organogenesis Holdings Inc’s (ORGO) raw stochastic average was set at 57.48%, which indicates a significant increase from 54.06% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.53 in the past 14 days, which was higher than the 0.28 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $4.62, while its 200-day Moving Average is $4.33. However, in the short run, Organogenesis Holdings Inc’s stock first resistance to watch stands at $5.81. Second resistance stands at $6.03. The third major resistance level sits at $6.37. If the price goes on to break the first support level at $5.25, it is likely to go to the next support level at $4.91. Now, if the price goes above the second support level, the third support stands at $4.69.
Organogenesis Holdings Inc (NASDAQ: ORGO) Key Stats
Market capitalization of the company is 709.44 million based on 126,912K outstanding shares. Right now, sales total 482,040 K and income totals 860 K. The company made 150,860 K in profit during its latest quarter, and 21,570 K in sales during its previous quarter.
